Bicillin C-r 900/300 Injection, Suspension
Product Images NDC 60793-602
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bicillin C-r 900/300 (NDC 60793-602). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemstructure 2 (Bicillin 02)
Logo (Bicillin 03)
Principal Display Panel (2 mL Syringe Label)
This is a description of a medication called BICILLIN® C-R 900/300. It is an injectable suspension that contains 900,000 units of penicillin G benzathine and 300,000 units of penicillin G procaine. It is distributed by a company and is intended for deep intramuscular injection only. It is important to note that this medication is not for the treatment of syphilis and can be fatal if given by other routes.*
Principal Display Panel (2 mL Syringe Carton)
Ten 2 mL syringes of Bicillin C-R 900/300 which is a penicillin G benzathine and procaine injectable suspension containing 1,200,000 units per 2 mL. This medication is intended for pediatric use and for deep intramuscular injection only. It is important to see the package insert for administration instructions before injecting. This medicine is not for the treatment of syphilis. The usual dosage is enclosed in the information. It is essential to store the medication at room temperature and keep it from freezing. The syringe has a 21-gauge needle and an unvarnished imprint area designed for pediatric use.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.